Language: English
Language: English
Navigating reimbursement for cellular therapies can be challenging, but a new eCast from the Association for the Advancement of Blood & Biotherapies (AABB) makes it easier.
Join us from 2 to 3 p.m. ET on Oct. 1 to:
✔️ Gain guidance straight from CMS.
✔️ Explore real-world case studies from health care facilities.
✔️ Get practical tools to navigate reimbursement efficiently.
Meet the speakers:
🔹 John Brooks, deputy administrator and chief policy and regulatory officer, Centers for Medicare & Medicaid Services.
🔹 WANXING CUI, PhD, CABP(H), director, cell therapy manufacturing facility, MedStar Georgetown University Hospital.
🔹 Susan N. Leppke, MPH, senior director, public policy and strategic partnerships, AABB.
🔹 Ronit Slotky, PhD, MSc, CABP, director, cell therapy manufacturing facility, Hackensack Meridian Health University Medical Center.
Speakers will cover recent CMS rule changes, share actionable strategies and highlight AABB’s advocacy efforts to support your facility.
